Immunohistochemistry Inhibin Alpha Test, Price, Normal Range | Sprint Diagnostics Hyderabad

The IHC - Inhibin Alpha test is commonly used to diagnose adrenal cortical tumors, sex cord-stromal tumors, and other types of tumors. It is especially significant in differentiating between various types of ovarian tumors and in identifying metastatic adrenal cortical carcinoma.

A positive result indicates the presence of inhibin alpha protein in the tissue sample. This could be indicative of a particular type of tumor, especially those related to the adrenal gland or sex cord-stromal tumors.

No, fasting is not required for the IHC - Inhibin Alpha test, as the test is performed on a tissue sample, usually obtained through a biopsy.

This test is not performed routinely but is specifically requested by your doctor based on your symptoms, medical history, and preliminary diagnostic results.

As this is a qualitative test, there isn't a specific 'normal' value. The presence or absence of inhibin alpha in the sample provides the required diagnostic information.

There are no specific precautions required for this test. However, you should inform your doctor of any medications you're taking, as certain drugs might influence the test results.

If your test results are abnormal, you should consult with the doctor who ordered the test, which could be an endocrinologist, oncologist, or pathologist, depending on your symptoms and medical history.

The primary factors that could affect your test results include improper sample collection or handling, as well as technical issues during the IHC process. It's important to have the test conducted in a reputable, quality-assured laboratory to ensure accuracy.

Yes, the IHC - Inhibin Alpha test is performed on an outpatient basis. The tissue sample can be taken from an outpatient biopsy, and the test itself is carried out in a laboratory.

The test itself isn't painful. However, the biopsy procedure to collect the tissue sample can cause some discomfort.

The test can be performed during pregnancy if it is medically necessary and the potential benefits outweigh the risks. As always, this should be discussed with your healthcare provider.

The presence of inhibin alpha can vary based on the age and gender of the patient, especially considering its role in reproductive health. However, the clinical interpretation of the test result would take these factors into account.

The risks associated with this test are primarily related to the biopsy procedure used to obtain the tissue sample. These might include pain, bleeding, or infection at the biopsy site.

Yes, you can take your medications as prescribed before the test. However, it's important to inform your healthcare provider about all the medications and supplements you're currently taking.

Yes, in addition to its role in diagnosing tumors, the inhibin alpha protein can also serve as a marker for certain gynecological conditions such as endometriosis and polycystic ovary syndrome (PCOS). However, it's essential to note that the use of IHC - Inhibin Alpha test would be guided by your symptoms and clinical presentation.

The IHC - Inhibin Alpha test is unique in its ability to detect the presence of the inhibin alpha protein, which is linked to certain types of tumors and conditions. This specificity makes it a valuable tool in differential diagnosis where the presence of certain types of tumors is suspected.

The test result is interpreted by a pathologist who assesses the presence or absence of the inhibin alpha protein in the tissue sample. A positive test indicates the presence of the protein, which could suggest a certain type of tumor or condition, depending on other clinical findings and diagnostic tests.

If the test result is inconclusive, your doctor may recommend additional testing or a repeat of the IHC - Inhibin Alpha test. An inconclusive result may occur due to technical issues during the test or an insufficient amount of tissue sample for testing.

While the IHC - Inhibin Alpha test is a powerful tool in diagnosing certain conditions, it does have its limitations. The test can only detect the presence of the inhibin alpha protein and cannot determine the specific nature or stage of the tumor. Furthermore, a negative test result does not necessarily rule out a disease, as the inhibin alpha protein may not be present in all cases of the suspected condition.

The IHC - Inhibin Alpha test is a sophisticated diagnostic tool that provides vital information about the presence of certain proteins linked to specific health conditions. However, like all tests, it should be used as part of a comprehensive diagnostic approach, including patient history, physical examination, and other relevant tests. Please remember to consult with your healthcare provider for any concerns or questions regarding this test. It's your health, and you have every right to understand and be involved in all aspects of your care.